Paper42965713PubMed
Antifungal pharmacotherapy of small intestinal fungal overgrowth: target-site exposure modelling, species-stratified target attainment, and stewardship in a provisional clinicomicrobiological construct.
Choudhary AK. Arch Microbiol, 2026.
Cite this record
ConductScience Library. Antifungal pharmacotherapy of small intestinal fungal overgrowth: target-site exposure modelling, species-stratified target attainment, and stewardship in a provisional clinicomicrobiological construct. Papers, record 42965713. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42965713
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
Antifungal pharmacotherapy of small intestinal fungal overgrowth: target-site exposure modelling, species-stratified target attainment, and stewardship in a provisional clinicomicrobiological construct.
- Journal
- Arch Microbiol
- Year
- 2026
- Publication types
- Journal Article, Review
- Revised in PubMed
- 2026-10-31
Source PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antifungal Agents | Major topic |
| Intestine, Small | Major topic |
| Mycoses | Major topic |
| Fungi | Major topic |
| Humans | |
| Microbial Sensitivity Tests | |
| Candida albicans | |
| Fluconazole | |
| Monte Carlo Method | |
| Biofilms | |
| Antimicrobial Stewardship |
Source PubMed
References85
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 41853095 | Small Intestinal Fungal Overgrowth Mimicking a Surgical Abdomen and Presenting as Bowel Obstruction: A Case Report and Literature Review. | Cureus | 2026 | https://conductscience.org/library/papers/41853095 | PubMed |
| 2 | 11577374 | A randomized, double-blind, double-dummy, multicenter trial of voriconazole and fluconazole in the treatment of esophageal candidiasis in immunocompromised patients. | Clin Infect Dis | 2001 | https://conductscience.org/library/papers/11577374 | PubMed |
| 3 | 12654644 | In vivo pharmacodynamics of antifungal drugs in treatment of candidiasis. | Antimicrob Agents Chemother | 2003 | https://conductscience.org/library/papers/12654644 | PubMed |
| 4 | 28911043 | Multidrug-Resistant Candida: Epidemiology, Molecular Mechanisms, and Treatment. | J Infect Dis | 2017 | https://conductscience.org/library/papers/28911043 | PubMed |
| 5 | 32562861 | How to interpret MICs of antifungal compounds according to the revised clinical breakpoints v. 10.0 European committee on antimicrobial susceptibility testing (EUCAST). | Clin Microbiol Infect | 2020 | https://conductscience.org/library/papers/32562861 | PubMed |
| 6 | 24379304 | Therapeutic drug monitoring (TDM) of antifungal agents: guidelines from the British Society for Medical Mycology. | J Antimicrob Chemother | 2014 | https://conductscience.org/library/papers/24379304 | PubMed |
| 7 | 30782643 | Associations between low- and high-dose oral fluconazole and pregnancy outcomes: 3 nested case-control studies. | CMAJ | 2019 | https://conductscience.org/library/papers/30782643 | PubMed |
| 8 | 32047294 | Drug resistance and tolerance in fungi. | Nat Rev Microbiol | 2020 | https://conductscience.org/library/papers/32047294 | PubMed |
| 9 | 40899797 | Name changes for fungi of medical importance, 2022-2024. | J Clin Microbiol | 2025 | https://conductscience.org/library/papers/40899797 | PubMed |
| 10 | 28624575 | Intestinal Fungal Dysbiosis Is Associated With Visceral Hypersensitivity in Patients With Irritable Bowel Syndrome and Rats. | Gastroenterology | 2017 | https://conductscience.org/library/papers/28624575 | PubMed |
| 11 | 37606364 | Oral Lipid Nanocrystal Amphotericin B for Cryptococcal Meningitis: A Randomized Clinical Trial. | Clin Infect Dis | 2023 | https://conductscience.org/library/papers/37606364 | PubMed |
| 12 | 2183713 | Amphotericin B: current understanding of mechanisms of action. | Antimicrob Agents Chemother | 1990 | https://conductscience.org/library/papers/2183713 | PubMed |
| 13 | 2184510 | Pharmacokinetics and tissue penetration of fluconazole in humans. | Rev Infect Dis | 1990 | https://conductscience.org/library/papers/2184510 | PubMed |
| 14 | 42118103 | Global surveillance of Candida albicans: MIC distributions, resistance patterns, and temporal trends from the Antimicrobial Testing Leadership and Surveillance program (2015-2024). | Antimicrob Agents Chemother | 2026 | https://conductscience.org/library/papers/42118103 | PubMed |
| 15 | 32323222 | Pharmacokinetics and Pharmacodynamics of Posaconazole. | Drugs | 2020 | https://conductscience.org/library/papers/32323222 | PubMed |
| 16 | 23315320 | Finding the "missing 50%" of invasive candidiasis: how nonculture diagnostics will improve understanding of disease spectrum and transform patient care. | Clin Infect Dis | 2013 | https://conductscience.org/library/papers/23315320 | PubMed |
| 17 | 5764842 | Fungal flora of the normal human small and large intestine. | N Engl J Med | 1969 | https://conductscience.org/library/papers/5764842 | PubMed |
| 18 | 39956121 | Global guideline for the diagnosis and management of candidiasis: an initiative of the ECMM in cooperation with ISHAM and ASM. | Lancet Infect Dis | 2025 | https://conductscience.org/library/papers/39956121 | PubMed |
| 19 | 15801925 | A randomized, double blind, comparative trial of micafungin (FK463) vs. fluconazole for the treatment of oesophageal candidiasis. | Aliment Pharmacol Ther | 2005 | https://conductscience.org/library/papers/15801925 | PubMed |
| 20 | 34716925 | Small bowel water content assessed by MRI in health and disease: a collation of single-centre studies. | Aliment Pharmacol Ther | 2022 | https://conductscience.org/library/papers/34716925 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42965713
GET https://conductscience.org/api/papers/v1/42965713/references?page=2